Cargando…
USP21 regulates Hippo pathway activity by mediating MARK protein turnover
The Hippo pathway, which acts to repress the activity of YAP and TAZ trancriptional co-activators, serve as a barrier for oncogenic transformation. Unlike other oncoproteins, YAP and TAZ are rarely activated by mutations or amplified in cancer. However, elevated YAP/TAZ activity is frequently observ...
Autores principales: | Nguyen, Hung Thanh, Kugler, Jan-Michael, Loya, Anand C., Cohen, Stephen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609986/ https://www.ncbi.nlm.nih.gov/pubmed/28969054 http://dx.doi.org/10.18632/oncotarget.19322 |
Ejemplares similares
-
Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover
por: Thanh Nguyen, Hung, et al.
Publicado: (2016) -
DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins
por: Nguyen, Hung Thanh, et al.
Publicado: (2017) -
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
por: Hong, Xin, et al.
Publicado: (2014) -
Ubiquitin-Dependent Regulation of the Mammalian Hippo Pathway: Therapeutic Implications for Cancer
por: Nguyen, Thanh Hung, et al.
Publicado: (2018) -
RhoBTB Proteins Regulate the Hippo Pathway by Antagonizing Ubiquitination of LKB1
por: Nguyen, Thanh Hung, et al.
Publicado: (2020)